Verona Pharma plc (VRNA) Tops Q3 EPS by 1c

Verona Pharma plc (NASDAQ: VRNA) reported Q3 EPS of ($0.02), $0.01 better than the analyst estimate of ($0.03).

For earnings history and earnings-related data on Verona Pharma plc (VRNA) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Goldman Sachs Starts Infratil New Zealand (IFT:NZ) at Buy
• JPMorgan Upgrades YDUQS Participacoes SA (YDUQ3:BZ) to Overweight